
Medical device maker Nevro Corp's shares NVRO.N rise 14.1% to $5.73, while Globus Medical GMED.N shares fall 4.5% to $88.22
Globus Medical to acquire all shares of Nevro in an all-cash transaction, representing a total equity value of ~$250 million
Deal offers $5.85 per share for each share of Nevro Corp, a premium of 16.5% to NVRO's last close
Deal is expected to close late in Q2 2025
In the last 12 months, GMED up 58.88%, while NVRO has fallen 60.78%